Now drug-resistant genes can be identified in less than half the time
06 June 2019
Researcher Emily Crawford of Chan Zuckerberg Biohub and UC San Francisco has created a gene-based technology — FLASH — that addresses this problem.
FLASH uses CRISPR/Cas9’s precise gene-targeting ability, plus a couple of classic molecular biology tricks to build a platform to amplify and sequence specific DNA molecules of pathogens with antimicrobial resistant genes.
Further reading: Down to Earth
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
